The Valley Desk

NCT01263015 · Interventional trial

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Overall registry status Completed

Phase 3

Conditions Infection, Human Immunodeficiency Virus I

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov